Comment
doi: 10.1002/bdra.20655.
Paroxetine exposure during pregnancy and cardiac malformations
Affiliations
- PMID: 20175190
- DOI: 10.1002/bdra.20655
Item in Clipboard
Comment
Paroxetine exposure during pregnancy and cardiac malformations
Birth Defects Res A Clin Mol Teratol.
2010 Mar.
No abstract available
Comment on
-
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70. doi: 10.1002/bdra.20627. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 19739149
Similar articles
-
Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):171-4. doi: 10.1002/bdra.20643. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 19950383 No abstract available.
-
First trimester exposure to paroxetine and prevalence of cardiac defects: Meta-analysis of the literature: Unfortunately incomplete.Birth Defects Res A Clin Mol Teratol. 2010 Jul;88(7):588; author reply 589. doi: 10.1002/bdra.20688. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 20602457 No abstract available.
-
First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies.Birth Defects Res A Clin Mol Teratol. 2010 Mar;88(3):159-70. doi: 10.1002/bdra.20627. Birth Defects Res A Clin Mol Teratol. 2010. PMID: 19739149
-
Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.J Clin Psychiatry. 2009 Mar;70(3):414-22. doi: 10.4088/jcp.08r04468. Epub 2009 Feb 24. J Clin Psychiatry. 2009. PMID: 19254517 Review.
-
Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.BMC Med. 2018 Nov 12;16(1):205. doi: 10.1186/s12916-018-1193-5. BMC Med. 2018. PMID: 30415641 Free PMC article.
Cited by
-
Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?Obstet Gynecol Int. 2012;2012:698947. doi: 10.1155/2012/698947. Epub 2011 Dec 10. Obstet Gynecol Int. 2012. PMID: 22190957 Free PMC article.
-
Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study.Eur J Epidemiol. 2015 Nov;30(11):1187-98. doi: 10.1007/s10654-015-0065-y. Epub 2015 Jul 7. Eur J Epidemiol. 2015. PMID: 26148560
-
Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection.Drug Saf. 2013 Nov;36(11):1069-78. doi: 10.1007/s40264-013-0082-2. Drug Saf. 2013. PMID: 23828658
-
Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.Drug Saf. 2011 Nov 1;34(11):1027-48. doi: 10.2165/11593130-000000000-00000. Drug Saf. 2011. PMID: 21981432 Review.
-
Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.Can Fam Physician. 2010 Aug;56(8):767-8. Can Fam Physician. 2010. PMID: 20705881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
